Company / Current Assets
Beta Bionics, Inc. Current Assets History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$267.9M
FY2025
5-year range
$103.6M / $267.9M
FY2023-FY2025
Trend
+101.5%
vs FY2024
Sector context
#140 of 160
Health Care
What the data says
Beta Bionics, Inc.'s current assets of $268M is lower than 87% of companies in the Health Care sector (FY2025). Improved from $104M to $268M over the past 2 years.
Based on SEC 10-K filings.
$268M in FY2025.
Improved from $104M to $268M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 160This company $267.9M Sector average $5.2B
▼
-94.9% below sector average
Key checks
Key Insights
- In FY2025, current assets increased 101.5% year-over-year.
- Ranks #140 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $267.9M | +101.5% |
| FY2024 | $132.9M | +28.3% |
| FY2023 | $103.6M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026